Pfizer

YTD

ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.

CEO

Albert Bourla

CEOAlbert Bourla

Employees

75,000

Employees75,000

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

1849

Founded1849

Employees

75,000

Employees75,000

PFE Key Statistics

Market cap

147.62B

Market cap147.62B

Price-Earnings ratio

19.86

Price-Earnings ratio19.86

Dividend yield

6.64%

Dividend yield6.64%

Average volume

32.42M

Average volume32.42M

High today

$26.15

High today$26.15

Low today

$25.76

Low today$25.76

Open price

$26.00

Open price$26.00

Volume

22.32M

Volume22.32M

52 Week high

$28.75

52 Week high$28.75

52 Week low

$22.88

52 Week low$22.88

Stock Snapshot

The current Pfizer(PFE) stock price is $25.90, with a market capitalization of 147.62B. The stock trades at a price-to-earnings (P/E) ratio of 19.86 and offers a dividend yield of 6.6%.

On 2026-05-24, Pfizer(PFE) stock traded between a low of $25.76 and a high of $26.15. Shares are currently priced at $25.90, which is +0.5% above the low and -1.0% below the high.

The Pfizer(PFE)'s current trading volume is 22.32M, compared to an average daily volume of 32.42M.

In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $22.88.

PFE News

Nasdaq 6h

What's the Better Dividend Stock Today: AbbVie or Pfizer?

Key Points Pfizer's dividend yield is far higher than AbbVie's, but the key issue is whether the payout is safe. AbbVie has been a dividend growth beast for s...

Simply Wall St 21h

Pfizer Collaboration Targets Faster Cancer Trials While Shares Trade Below Value

Pfizer (NYSE:PFE) and Sarah Cannon Research Institute have agreed to work together using SCRI’s Accelero platform to speed up oncology clinical trials. The col...

TipRanks 1d

Pfizer Juggles Trial Win, Setback and New Vaccine Bet

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Meet Samuel – Your Personal Investing Prophet Start...

Analyst ratings

54%

of 28 ratings

Buy

35.7%

Hold

53.6%

Sell

10.7%

More PFE News

The Motley Fool 2d

The Most Important Healthcare Stock You're Not Watching

A company with a $140 billion market cap is very large. It is also highly likely to be an important player in the industry where it competes. But that doesn't s...